The current job opportunity is supported by the Dutch Research Council funded project entitled “Time Dynamics in Bioprinting: Steering Organoid Maturation and Therapeutic Stem Cell Manufacturing” (TIMESTAMP, VIDI Talent Program,
Dr. R. Levato). You will join our international and multidisciplinary team at the Living Matter Engineering & Biofabrication research group, also funded by the European Research Council and the European Innovation Council.
Three-dimensional (3D) bioprinting and organoid technologies hold the promise to revolutionise medicine, building lab-made tissues that mimic human organ parts, enabling new applications in regenerative medicine and pharmaceutical research, as potential alternatives to animal experimentation. Living tissues owe their function not only to their architecture, but also to maturation and morphogenesis, processes guided by patterns of biochemical and mechanical signals that evolve over time, and instruct cells in their proximity. However, control over the time dimension is absent in current bioprinted constructs and in most biomaterials for 3D tissue culture, thus precluding the precise replication of such dynamic changes occurring in the native extracellular environment.
Advances in key technologies capturing this shape-function relationship in vitro can bring the long-sought goal of real tissue engineering within reach. In TIMESTAMP, we will develop a new bioprinting technique capable to directly guide tissue maturation by tuning the cellular microenvironment over time, dynamically matching the needs of cells during their natural differentiation process. For this, we will develop novel light responsive biomaterials able to change their mechano-chemical properties on demand, and a new volumetric bioprinting technology under development in our lab. Unlike conventional, layer-by-layer additive manufacturing, this new technique uses visible light to generate complex, large-scale living tissue constructs with an unprecedented degree of fidelity and printing velocity (<10 seconds).
Bringing together expertise in bioprinting, material design, photonics, artificial intelligence, organoids and stem cell biology, this project will first test the potential and versatility of this novel technology by building vascularised organoids to produce hematopoietic stem cells needed in the clinics for treating blood cancers. Joining our biofabrication team, you will contribute to the goals of the project by focusing on the development of new photoresponsive and stimuli-responsive materials for the state-of-the-art volumetric bioprinting techniques under development in our center and for organoids 3D culture. These innovative hydrogels will permit cell-driven tissue morphogenesis, thus requiring the targeting of very diverse chemical and physical properties, as well as the ability of such materials to respond dynamically to cell-induced stimuli. Interactions and collaboration with a multidisciplinary team of clinicians, biologists, physicists, engineers, computer scientists, clinicians and veterinary doctors form an essential part of the job.